Document is current
Any future updates will be listed below
-
Authors
Hagenström, Kristina https://orcid.org/0000-0002-2676-1479
Müller, Katharina https://orcid.org/0009-0004-5797-4014
Klinger, Theresa https://orcid.org/0009-0003-0760-3103
Stephan, Brigitte https://orcid.org/0000-0001-6127-3692
Augustin, Matthias https://orcid.org/0000-0002-4026-8728
-
Funding
Funding for this research was provided by:
Galderma Laboratorium GmbH
- License Information
-
More Information
Article History
Received: 31 May 2024
Accepted: 20 September 2024
First Online: 18 October 2024
Declarations
:
: Kristina Hagenström, Katharina Müller and Theresa Klinger declare no conflicts of interest. Brigitte Stephan has received payments/honoraria for lectures and presentations and/or received grants and/or participated in clinical trials including from the following companies: AbbVie, Almirall Hermal, Amgen, Beiersdorf, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Glaxo SmithKline, Janssen-Cilag, LEO Pharma, Lilly, Medac, Novartis, Pierre Fabre, Sanofi Aventis and UCB. Matthias Augustin has received institutional research funding, travel grants and lecture fees from companies which produce products for acne, including Almirall, Beiersdorf, Galderma and GSKx.
: The study was conducted according to the principles expressed in the Declaration of Helsinki. We took the criteria of a National Good Practice Guideline into consideration [, ]. According to the Good Practice of Secondary Data Analysis, no approval of an ethical committee is required. Permission was granted to access the data used in this study.
